Research Briefs: First Implants Of Edwards’ Transcatheter Mitral Valve; AF Ablation Catheters Trials
This article was originally published in The Gray Sheet
Executive Summary
Three patients have received Edwards Lifesciences’ Fortis transcatheter mitral valve. Heart Rhythm publishes results from trials of Biosense Webster’s nMARQ atrial fibrillation ablation mapping catheter and Medtronic’s Arctic Front Advance cryoballoon AF ablation catheter. More research news.
You may also be interested in...
New Products In Brief
Debuts include Medtronic’s next-generation Arctic Front Advance for paroxysmal atrial fibrillation, Covidien’s iDrive Ultra surgical stapler and AngioDynamics’ BioFlo peripherally inserted central catheters.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.